This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Lowenstein, C. J. Search for Related Content PubMed PubMed Citation Articles by Lowenstein, C. J. Related Collections Animal models of human disease Heart failure - basic studies Related Article

(Circulation. 2004;110:1178-1179.)
© 2004 American Heart Association, Inc.

Editorial

Exogenous Thioredoxin Reduces Inflammation in Autoimmune Myocarditis

Charles J. Lowenstein

From the Division of Cardiology, Departments of Medicine and Pathology, The Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Charles J. Lowenstein, 950 Ross Building, The Johns Hopkins University School of Medicine, 720 Rutland Ave, Baltimore, MD 21205. E-mail clowenst@jhmi.edu

Key Words: Editorials • myocarditis • inflammation • oxygen

An extract of the first 250 words of the full text is provided, because this article has no abstract.

Levels of reactive oxygen species (ROS) are tightly regulated in mammalian cells. A variety of enzymes produce ROS, including NAD(P)H oxidase, xanthine oxidase, glucose oxidase, myeloperoxidase, the family of nitric oxide synthases, and mitochondrial enzymes.^1–4 Low levels of ROS such as superoxide or hydrogen peroxide regulate highly specific targets.^5,6 In the cardiovascular system, for example, ROS serve as signaling molecules, mediating vascular endothelial growth factor signal transduction, activating matrix metalloproteinases, and regulating cell cycle phosphatases. Host defenses that protect against oxidative stress include small antioxidant molecules such as ascorbate, -tocopherol, glutathione, and thioredoxin (Trx), as well as antioxidant enzymes such as superoxide dismutase, catalase, paraoxonase, glutathione reductase, glutathione peroxidase, and Trx reductase.

See p 1276

However, excessive oxidative stress—caused by either increased ROS production or inadequate antioxidant defenses—can lead to cardiovascular diseases. For example, genetic deficiency of glutathione peroxidase-1 is associated with increased levels of vascular hydrogen peroxide and arterial thrombosis.^7,8 Another example of an imbalance in oxidant stress occurs when elevated levels of angiotensin II trigger excess ROS production by the vascular NAD(P)H oxidase Mox1, contributing to decreased nitric oxide bioavailability, endothelial dysfunction, and atherogenesis.^9,10 Additionally, increased levels of ROS generated by xanthine oxidase in the heart impair cardiac energetics, playing a role in the development of cardiomyopathy.^11,12 Finally, ROS may play a critical role in autoimmune myocarditis.

Autoimmunity is surprisingly common in patients with cardiomyopathy: Up to 20% of all idiopathic dilated cardiomyopathies are associated with autoantibodies and other autoimmune markers.¹³ Triggers of autoimmune myocarditis include (1) molecular . . . [Full Text of this Article]

Related Article:

Thioredoxin-1 Ameliorates Myosin-Induced Autoimmune Myocarditis by Suppressing Chemokine Expressions and Leukocyte Chemotaxis in Mice

Wenrui Liu, Hajime Nakamura, Keisuke Shioji, Masaki Tanito, Shin-ichi Oka, M. Kaimul Ahsan, Aoi Son, Yasuyuki Ishii, Chiharu Kishimoto, and Junji Yodoi
Circulation 2004 110: 1276-1283. [Abstract] [Full Text]